Celularity
CELU
38 hedge funds and large institutions have $2.88M invested in Celularity in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 6 closing their positions.
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
6% more funds holding
Funds holding: 36 → 38 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.25% less ownership
Funds ownership: 7.77% → 7.52% (-0.25%)
10% less capital invested
Capital invested by funds: $3.19M → $2.88M (-$306K)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$39.1K |
| 2 |
CAM
CenterStar Asset Management
Chicago,
Illinois
|
+$22.6K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$18.8K |
| 4 |
HF
HRT Financial
New York
|
+$16.2K |
| 5 |
BlackRock
New York
|
+$16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$86.2K |
| 2 |
Jane Street
New York
|
-$45.9K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$20.9K |
| 4 |
PIA
Perennial Investment Advisors
Los Angeles,
California
|
-$15.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$13K |
CELU Hedge Fund Activity: Q1 2026 in Review
38 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q1 2026, worth a combined $2.88M — down 9.6% from $3.19M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CELU positions and 6 closed out — a net gain of 4 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $39.1K. The largest seller was Citadel Advisors, exiting entirely with an estimated $86.2K sold.
- 38 institutional investors held Celularity (CELU) as of Q1 2026, up from 36 in Q4 2025.
- Funds reported $2.88M of Celularity stock for Q1 2026, down 9.6% quarter-over-quarter.
- 10 funds opened new Celularity positions in Q1 2026 and 6 closed out, a net change of +4 holders.
- The largest Celularity buyer in Q1 2026 was Geode Capital Management, an estimated $39.1K added.
- The largest Celularity seller in Q1 2026 was Citadel Advisors, an estimated $86.2K sold.
Based on aggregated 13F filings for Q1 2026.